Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study and Literature Review.
Simple Summary: Recurrent or metastatic head and neck squamous cell carcinoma is a challenging disease that often requires systemic treatment. For many years, the combination of chemotherapy and the targeted agent cetuximab (the EXTREME regimen) was the standard first-line therapy. Although immunoth...
| Publicado en: | Current Oncology Vol. 33; no. 4; pp. 183 - 197 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Apr2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |